Divi's Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Divi's Laboratories has a total shareholder equity of ₹126.8B and total debt of ₹50.0M, which brings its debt-to-equity ratio to 0.04%. Its total assets and total liabilities are ₹142.8B and ₹16.1B respectively. Divi's Laboratories's EBIT is ₹15.9B making its interest coverage ratio -7.8. It has cash and short-term investments of ₹36.1B.
Key information
0.04%
Debt to equity ratio
₹50.00m
Debt
Interest coverage ratio | -7.8x |
Cash | ₹36.11b |
Equity | ₹126.77b |
Total liabilities | ₹16.06b |
Total assets | ₹142.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532488's short term assets (₹88.8B) exceed its short term liabilities (₹10.1B).
Long Term Liabilities: 532488's short term assets (₹88.8B) exceed its long term liabilities (₹6.0B).
Debt to Equity History and Analysis
Debt Level: 532488 has more cash than its total debt.
Reducing Debt: 532488's debt to equity ratio has reduced from 1.4% to 0.04% over the past 5 years.
Debt Coverage: 532488's debt is well covered by operating cash flow (30254.6%).
Interest Coverage: 532488 earns more interest than it pays, so coverage of interest payments is not a concern.